Premium
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
